Test environment running 7.6.6

Cultural advice

The Australian National University acknowledges, celebrates and pays our respects to the Ngunnawal and Ngambri people of the Canberra region and to all First Nations Australians on whose traditional lands we meet and work, and whose cultures are among the oldest continuing cultures in human history.

Aboriginal and Torres Strait Islander peoples are advised that ANU Library collections may include images, names, voices, and other representations of deceased persons.

Material in the collection may contain terms, language or views that reflect the period in which the item was created and may be considered inappropriate today.

GreenLight HPS 120-W Laser for Benign Prostatic Hyperplasia

Abstract

The most common surgical procedure for symptomatic benign prostatic hyperplasia is transurethral resection of the prostate. However, this procedure has complications, including bleeding, erectile dysfunction, and retrograde ejaculation. Alternative therapies have been developed with the aim of reducing the level of complications while maintaining efficacy. These include microwave therapy, transurethral needle ablation, and a range of laser procedures. Recently, photoselective vaporization of the prostate (PVP) was introduced using the GreenLight 60-W laser (American Medical Systems, Minnetonka, Minnesota, USA) and later the 80-W laser, which is the predominant device used in PVP trials. The latest evolution is the GreenLight HPS 120-W laser (532 nm), which produces not only rapid vaporization of prostate tissue but also an acceptable rate of complications. Here we present a review of complications associated with surgical therapies for benign prostatic hyperplasia including data on the initial use of the GreenLight HPS 120-W system. Recommendations are provided on how the low complication rates achieved with PVP can be reduced even further through modification of the operating procedure.

Description

Citation

Source

European Urology, Supplements

Book Title

Entity type

Access Statement

License Rights

Restricted until